Crossref
Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors
Journal of Chinese Pharmaceutical Sciences · 30.04.2026 · 35 (4) · 329
DOI: 10.5246/jcps.2026.04.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.04.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors. Journal of Chinese Pharmaceutical Sciences, 35(4), 329. https://doi.org/10.5246/jcps.2026.04.022
Vancouver
Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors. Journal of Chinese Pharmaceutical Sciences. 2026;35(4):329. doi:10.5246/jcps.2026.04.022
BibTeX
@article{euvimed2026,
title = {Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors},
journal = {Journal of Chinese Pharmaceutical Sciences},
year = {2026},
volume = {35},
number = {4},
pages = {329},
doi = {10.5246/jcps.2026.04.022}
}
EUVIMED